Scholarlink

<p>Napyradiomycins (NPDs), a family of structurally diverse terpenoids isolated from <i>Streptomyces</i>, have attracted significant scientific interest due to their unique halogenation patterns and potent bioactivities. Since identifying the first member from <i>Streptomyces</i> in 1986, over 50 NPDs have been characterized, demonstrating remarkable efficacy against drug-resistant bacteria and cancer cells, making them promising candidates for novel drug development. In this review, we provided an in-depth exploration of the complex chemical structure of NPDs, their diverse bioactivities, and the biosynthetic pathways involved in their formation. In particular, we collectively concluded the structure-activity relationship data to highlight the importance of the molecular features of napyradiomycins determining their therapeutic potential. Recent discoveries have shed light on the unique role of halogenases, which contribute to the structural diversity and enhance the biological potency of napyradiomycins, thus refining the known biosynthetic pathways. The data presented here aims to stimulate further research and facilitate the advancement of NPDs toward becoming first-line therapies for infectious diseases and cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Insights for napyradiomycin family: structures, bioactivities and biosynthetic pathways

  • 期刊论文

  • 发表日期：

    2025年3月13日

查看全文
  • Nuo Chen,
  • Zinian Zhang,
  • Hangzhen Lan,
  • Huamao Wei,
  • Shuai Zhi,
  • Liwei Liu

摘要

Napyradiomycins (NPDs), a family of structurally diverse terpenoids isolated from Streptomyces, have attracted significant scientific interest due to their unique halogenation patterns and potent bioactivities. Since identifying the first member from Streptomyces in 1986, over 50 NPDs have been characterized, demonstrating remarkable efficacy against drug-resistant bacteria and cancer cells, making them promising candidates for novel drug development. In this review, we provided an in-depth exploration of the complex chemical structure of NPDs, their diverse bioactivities, and the biosynthetic pathways involved in their formation. In particular, we collectively concluded the structure-activity relationship data to highlight the importance of the molecular features of napyradiomycins determining their therapeutic potential. Recent discoveries have shed light on the unique role of halogenases, which contribute to the structural diversity and enhance the biological potency of napyradiomycins, thus refining the known biosynthetic pathways. The data presented here aims to stimulate further research and facilitate the advancement of NPDs toward becoming first-line therapies for infectious diseases and cancer.